Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Duton just updated with todays news

My guess would be #2.. because the time for #1 was fast approaching

Tho IMO I do not believe the reexamination processes are done (esp '336), since Pubpat probably has been initiated by parties completely outside of this litigation.. ie Gen Atl Part et al..

Share
New Message
Please login to post a reply